The latest news & stories from the Providence Research Network
-
Read ArticleProvidence study reveals strategies to improve heart disease treatment adherence
A recently published Providence Research Network study found that patient-provider communication, unmet social needs, and other factors can influence whether patients adhere to their ASCVD treatments.
-
Read ArticleProvidence research in the news: Can AI reduce documentation burden & burnout for healthcare providers?
An interview with Providence researchers for the news website Healthcare Intelligence looks at findings from a recent study on the impact of an AI solution on provider documentation burden and burnout
-
Read ArticleShe refused to let breast cancer dim her shine
When metastatic breast cancer rocked Renee Leaf's world, she found strength in her life's treasures and a Providence Swedish care team determined to save her life. Watch the video and learn more.
-
Read ArticleA new cancer therapy at Providence helps immune cells stand their ground
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
-
Read ArticleProvidence study finds AI clinical assistant reduces provider burnout
In a Providence study published last week in the Future Healthcare Journal, physicians reported significant reductions in burnout when using DAX Copilot.
-
Read ArticleUnlocking the promise of PGx: Insights from CORE
Research and an environmental scan by the Center for Outcomes Research & Education (CORE) offer key lessons for healthcare leaders working to advance Pharmacogenetic screenings in healthcare settings.
-
Read ArticleA new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
-
Read ArticleNew Study: Providence whole genome sequencing program shows transformative potential for population health
Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.
-
Read ArticleCORE study offers new data on Medicaid health-related housing benefits
Recognizing the links between housing and health, Medicaid programs are testing new housing benefit programs. Research by Providence CORE published in JAMA offers valuable insights for these efforts.
-
Read ArticleAdvancing personalized treatments for gliomas at Providence Brain & Spine Institute
For decades, brain cancer has remained one of the most difficult forms of cancer to treat. A new wave of research and advances in personalized treatments are bringing new hope.
-
Read ArticleNew Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research
Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.
-
Read ArticleProvidence researchers share cancer discoveries at 2025 ASCO meeting
Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.
-
Read ArticleProvidence sees dramatic rise in goals of care conversations after implementing system-wide changes
Providence documented and tracked more than 8,500 goals of care conversations in its electronic health record for critical care patients in 2024.
-
Read ArticlePersonalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
-
Read ArticleClinical trials matter, just ask Randy
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
-
Read ArticleStriking disparities in off-label GLP-1 prescribing revealed by study co-authored at Providence
Research co-authored by Providence CARDS found striking disparities in off-label prescribing of the popular GLP1-RA medications initially FDA-approved for diabetes and more recently for weight loss
-
Read ArticleSeeking better treatments for people with ER+/HER- breast cancer
Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.
-
Read ArticleStudies to be presented by Providence researchers at AACR annual meeting
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
-
Read ArticleCORE's 2024 annual report
CORE's annual report highlights some of the impactful and promising research, programs, and partnerships that we supported last year.
-
Read ArticleTed Lowenkopf, M.D., medical director of Providence St. Vincent Stroke Center, retires
Read about Dr. Lowenkopf’s storied 25-year career and his transformative work in stroke care, plus a personal message from Dr. Lowenkopf.
-
Loading More...
